BSX · 10-Q · 2026Q3 · Full report
Income Tax Rate Changes
BOSTON SCIENTIFIC CORP · 2026-11-02 · Importance 71 · Surprise 82 · Matches filing data
The reported tax rate for the first nine months of 2026 was 4.5%, compared with 17.2% in the same 2025 period; the rate from continuing operations was 17.4% versus 18.1%. A $383 million discrete tax benefit in the first quarter reflected a change in the anticipated future tax rate for recovery of certain capitalized expenses. In the third quarter, the reported tax rate was 20.8%, compared with 22.9% a year earlier, while the continuing-operations rate was 17.6% versus 18.1%. Third-quarter differences primarily reflected discrete charges related to return-to-provision adjustments.
Key facts
- Boston Scientific recorded a $383 million discrete tax benefit in the first nine months of 2026 to reflect a change in the anticipated future tax rate for recovery of certain capitalized expenses. source
- The OECD Pillar Two global minimum tax had no impact on Boston Scientific's continuing-operations tax rate in the third quarter of 2026; adoption of the January 5, 2026 safe-harbor guidance is not expected to materially affect that rate. source
- Boston Scientific's reported tax rate was 20.8% for the third quarter of 2026 and 19.5% for the first nine months of 2026; the corresponding continuing-operations rates were 17.6% and 17.4%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | realized | +7.5% | Boston Scientific recorded a $383 million discrete tax benefit in the first nine months of 2026 to reflect a change in the anticipated… |